Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: content day coming
Gene Therapy Keep your gene therapy development on track The paradigm of regenerative medicine development is changing. Expedited regulatory approvals can help developers, but only if they are timely with strategic planning and fully versed in the latest …
Rare Diseases A Wealth of Experience We have collaborated with our clients on projects to research rare diseases, rare disease treatment, and complications and comorbidities of rare diseases. Our experience includes: Acromegaly Amyotrophic lateral …
FDA’s Sentinel Initiative Driving Sound Research Practices for COVID-19 Vaccine Development Share on: November 11, 2021 RTI-HS is collaborating with the FDA to ensure that rigorous, valid methods are used to evaluate COVID-19 vaccine effectiveness in the …
Forbes Magazine Recognizes RTI International as One of the Best Employers for Diversity Share on: April 26, 2024 The 2024 America’s Best Employers for Diversity rankings resulted from surveying 170,000 US employees RESEARCH TRIANGLE PARK, N.C. — …
RTI International Acquires Medical Data Analytics Share on: April 6, 2020 Combination expands offering of real-world data/real-world evidence (RWD/RWE) to the world’s leading pharmaceutical and biotech companies RESEARCH TRIANGLE PARK, NC—RTI …
Mounting Evidence Suggests Century-Old Hypothesis on How Major Arteries Function is Incorrect Share on: September 17, 2017 Emergence of a new paradigm in understanding the cardiovascular system: pulse synchronized contractions has been published in the …
Identifying an Appropriate Drug for Comparative Safety Research Antiepileptic Drugs in Pregnancy: Searching for a Reference Drug for Comparative Safety AV Margulis , AS Oberg, S Hernandez-Diaz. Poster presented at the 33rd International Conference on …
A Cost-Effectiveness Analysis Using Real-World Data William Herring, PhD Director, Health Economics RTI Health Solutions A Cost-Effectiveness Analysis Using Real-World Data from the MSBase Registry: Comparing Natalizumab to Fingolimod in Patients with …
Is Investment to Increase Vaccination in Older Adults Worth the Cost? Share on: October 5, 2021 Gaining optimal vaccination coverage for older adults in the US Health guidelines recommend that older adults in the US be vaccinated for vaccine-preventable …
Infectious Disease A Wealth of Experience We have collaborated with our clients on projects to research infectious disease, infectious disease treatment, and complications and comorbidities of infectious disease. Our experience includes: Cholera COVID-19 …